相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
Esther Molina-Montes et al.
GUT (2021)
Effect of Metabolic Health and Obesity Phenotype on the Risk of Pancreatic Cancer: A Nationwide Population-Based Cohort Study
Hye Soo Chung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes
Stefano Menini et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells
Masahiro Watanabe et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2020)
Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American US Veterans with Diabetes Mellitus
Adetunji T. Toriola et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer
Thomas Hank et al.
PANCREATOLOGY (2020)
The intricate relationship between diabetes, obesity and pancreatic cancer
Silvano Paternoster et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer
Ye Lu et al.
JOURNAL OF MEDICAL GENETICS (2020)
Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab
Justine Bellier et al.
CELL REPORTS (2020)
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma
Katherine Minjee Chung et al.
CELL (2020)
An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases
Philip J. Broadhurst et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
Bao Quoc Lam et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Association between Metformin Use and Clinical Outcomes Following Pancreaticoduodenectomy in Patients with Type 2 Diabetes and Pancreatic Ductal Adenocarcinoma
Daegwang Yoo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress inKras(G12D/+)mice
Stefano Menini et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort
Veronica Wendy Setiawan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort
Veronica Wendy Setiawan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Global trends in diabetes complications: a review of current evidence
Jessica L. Harding et al.
DIABETOLOGIA (2019)
Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
Dan Wang et al.
CELL COMMUNICATION AND SIGNALING (2019)
High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells
Chun-Mei Hu et al.
CELL METABOLISM (2019)
Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Min Wei et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging
Thibault Teissier et al.
BIOGERONTOLOGY (2019)
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
Maria Teresa Blasco et al.
CANCER CELL (2019)
The Impact of Serum Glucose in the Treatment of Locoregionally Advanced Pancreatic Cancer
Nick A. Iarrobino et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma
Anne Wynn et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
In Vitro Anticancer Activities of B6 Vitamers: A Mini-review
Taisuke Matsuo et al.
ANTICANCER RESEARCH (2019)
Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study
Jaelim Cho et al.
DIABETES CARE (2019)
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Yongde Luo et al.
GASTROENTEROLOGY (2019)
The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study
Dong-Hoe Koo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
Yan Li et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality
Pranay Ramteke et al.
CANCERS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
Marco Mol et al.
REDOX BIOLOGY (2019)
Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer
Marie-Julie Nokin et al.
BREAST CANCER RESEARCH (2019)
Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?
Marco Gallo et al.
CANCER TREATMENT REVIEWS (2018)
Carnosine Catalyzes the Formation of the Oligo/Polymeric Products of Methylglyoxal
Tim Weigand et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis
Ayush Sharma et al.
GASTROENTEROLOGY (2018)
Do all roads lead to the Rome? The glycation perspective!
Saheem Ahmad et al.
SEMINARS IN CANCER BIOLOGY (2018)
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Saheem Ahmad et al.
SEMINARS IN CANCER BIOLOGY (2018)
Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model
Hui-Hua Chang et al.
SCIENTIFIC REPORTS (2018)
The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
Da Young Lee et al.
SCIENTIFIC REPORTS (2018)
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort
Thibault Fiolet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort
Thibault Fiolet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women
Donna L. White et al.
CANCER MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications
David Schroeter et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
Estifanos Baye et al.
NUTRIENTS (2018)
Is Preparation for Oxidative Stress a Case of Physiological Conditioning Hormesis?
Marcus F. Oliveira et al.
FRONTIERS IN PHYSIOLOGY (2018)
Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study
Weiheng Wen et al.
DIABETES THERAPY (2018)
A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
R. Dankner et al.
CANCER EPIDEMIOLOGY (2018)
Therapeutic potential of carbonyl-scavenging carnosine derivative in metabolic disorders
Jacob M. Haus et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress
Ethan J. Anderson et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data
Stefano Menini et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice
Carla Iacobini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies
Yuanjie Pang et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC)
Marcus Hollenbach
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study
Robert Carreras-Torres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma
Vicente Morales-Oyarvide et al.
PANCREATOLOGY (2017)
The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study
Robert Carreras-Torres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice
Hui-Hua Chang et al.
PLOS ONE (2017)
Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice
Thomas Albrecht et al.
SCIENTIFIC REPORTS (2017)
Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death
Marie-Julie Nokin et al.
SCIENTIFIC REPORTS (2017)
Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review
Austin Huy Nguyen et al.
ANTICANCER RESEARCH (2017)
RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer
Nancy Azizan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Biological impact of advanced glycation endproducts on estrogen receptor-positive MCF-7 breast cancer cells
Sabine Matou-Nasri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Fasting but not casual blood glucose is associated with pancreatic cancer mortality in Japanese: EPOCH-JAPAN
Masato Nagai et al.
CANCER CAUSES & CONTROL (2017)
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer
Dana K. Andersen et al.
DIABETES (2017)
DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity
Fabrizio Gentile et al.
AIMS GENETICS (2017)
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Mingzhan Xue et al.
DIABETES (2016)
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
Bendix Carstensen et al.
DIABETOLOGIA (2016)
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling
Ralph Gruber et al.
GASTROENTEROLOGY (2016)
Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer
Kathleen M. Hertzer et al.
PANCREAS (2016)
Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients
Erica Dugnani et al.
PANCREATOLOGY (2016)
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
Joao Incio et al.
CANCER DISCOVERY (2016)
Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis
Marie-Julie Nokin et al.
ELIFE (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect
Luca Regazzoni et al.
SCIENTIFIC REPORTS (2016)
Intrinsic carnosine metabolism in the human kidney
Verena Peters et al.
AMINO ACIDS (2015)
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
Yunxia Lu et al.
BRITISH JOURNAL OF CANCER (2015)
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
James D. Lewis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Andy Menke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study
Li Jiao et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Ratio of Serum Levels of AGEs to Soluble Form of RAGE Is a Predictor of Endothelial Function
Masato Kajikawa et al.
DIABETES CARE (2015)
Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
Jessica L. Harding et al.
DIABETES CARE (2015)
Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice
Stefano Menini et al.
DIABETOLOGIA (2015)
Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis
Shanshan Song et al.
PLOS ONE (2015)
Vitamin B and its derivatives for diabetic kidney disease
Amit D. Raval et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma
Jun-ichi Takino et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients
Gianpaolo Balzano et al.
ACTA DIABETOLOGICA (2014)
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium
C. Bosetti et al.
ANNALS OF ONCOLOGY (2014)
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Pikli Batabyal et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The Critical Role of Methylglyoxal and Glyoxalase 1 in Diabetic Nephropathy
Naila Rabbani et al.
DIABETES (2014)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2014)
The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
R. Kang et al.
ONCOGENE (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
Unlocking the biology of RAGE in diabetic microvascular complications
Michaele B. Manigrasso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
R. Kang et al.
CELL DEATH & DISEASE (2014)
Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes
Barbara Chiavarina et al.
ONCOTARGET (2014)
Role of advanced glycation end products in cellular signaling
Christiane Ott et al.
REDOX BIOLOGY (2014)
The glyoxalase pathway: the first hundred years ... and beyond
Marta Sousa Silva et al.
BIOCHEMICAL JOURNAL (2013)
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
Joanne W. Elena et al.
CANCER CAUSES & CONTROL (2013)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Christian Rask-Madsen et al.
CELL METABOLISM (2013)
A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice
Bincy Philip et al.
GASTROENTEROLOGY (2013)
Receptor for Advanced Glycation Endproducts (RAGE) Is a Key Regulator of Oval Cell Activation and Inflammation-Associated Liver Carcinogenesis in Mice
Tobias Pusterla et al.
HEPATOLOGY (2013)
The Receptor for Advanced Glycation End Products Promotes Pancreatic Carcinogenesis and Accumulation of Myeloid-Derived Suppressor Cells
Philip J. Vernon et al.
JOURNAL OF IMMUNOLOGY (2013)
CD166/ALCAM Mediates Proinflammatory Effects of S100B in Delayed Type Hypersensitivity
Ruediger von Bauer et al.
JOURNAL OF IMMUNOLOGY (2013)
Hyperglycemia, Insulin Resistance, Impaired Pancreatic -Cell Function, and Risk of Pancreatic Cancer
Brian M. Wolpin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
New insights into pancreatic cancer-induced paraneoplastic diabetes
Raghuwansh P. Sah et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Pancreatic cancer: why is it so hard to treat?
Paul E. Oberstein et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
A multicellular signal transduction network of AGE/RAGE signaling
Sowmya Soman et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)
Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs
Giulio Vistoli et al.
AMINO ACIDS (2012)
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies
D. Aune et al.
ANNALS OF ONCOLOGY (2012)
AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway
Rui Kang et al.
AUTOPHAGY (2012)
D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation
Stefano Menini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
Carolina Navas et al.
CANCER CELL (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
Thiruvengadam Arumugam et al.
CLINICAL CANCER RESEARCH (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma
Liguo Lin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Pyridorin in Type 2 Diabetic Nephropathy
Edmund J. Lewis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Type 2 Diabetes Mellitus: A Possible Surgically Reversible Intestinal Dysfunction
Priscila C. Sala et al.
OBESITY SURGERY (2012)
The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia
Rui Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
The Receptor for Advanced Glycation End-Products (RAGE) Protects Pancreatic Tumor Cells Against Oxidative Injury
Rui Kang et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Heat-shock protein 27 (Hsp27) as a target of methylglyoxal in gastrointestinal cancer
Tomoko Oya-Ito et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies
Donghui Li et al.
CANCER CAUSES & CONTROL (2011)
Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study
Li Jiao et al.
CANCER RESEARCH (2011)
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Qiwen Ben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes
Lian Engelen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study
Kevin Y. Urayama et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats
Olaf Brouwers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
Giancarlo Aldini et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diabetes and Pancreatic Cancer Chicken or Egg?
J. Trent Magruder et al.
PANCREAS (2011)
The hormesis database: The occurrence of hormetic dose responses in the toxicological literature
Edward J. Calabrese et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Past Medical History and Pancreatic Cancer Risk: Results From a Multicenter Case-Control Study
Patrick Maisonneuve et al.
ANNALS OF EPIDEMIOLOGY (2010)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden
X. Shu et al.
DIABETIC MEDICINE (2010)
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
A. Alkhalaf et al.
DIABETOLOGIA (2010)
Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1)
Jakub Drozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
C. Kahlert et al.
BRITISH JOURNAL OF CANCER (2009)
Glycemic Index, Carbohydrates, Glycemic Load, and the Risk of Pancreatic Cancer in a Prospective Cohort Study
Li Jiao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The receptor RAGE: Bridging inflammation and cancer
Astrid Riehl et al.
CELL COMMUNICATION AND SIGNALING (2009)
Hormesis and medicine
Edward J. Calabrese
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors
A. Negre-Salvayre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus
Rahul Pannala et al.
GASTROENTEROLOGY (2008)
RAGE signaling sustains inflammation and promotes tumor development
Christoffer Gebhardt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers
S. Yamagishi et al.
MEDICAL HYPOTHESES (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls
Giancarlo Aldini et al.
MEDICINAL RESEARCH REVIEWS (2007)
L-carnosine, a substrate of carnosinase-1, influences glucose metabolism
Sibylle Sauerhoefer et al.
DIABETES (2007)
Malondialdehyde scavenging and aldose-derived Schiff bases' transglycation properties of synthetic histidyl-hydrazide carnosine analogs
Andrea Guiotto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Reactive carbonyls and oxidative stress: Potential for therapeutic intervention
Elizabeth M. Ellis
PHARMACOLOGY & THERAPEUTICS (2007)
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
R. J. Stevens et al.
BRITISH JOURNAL OF CANCER (2007)
Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy
Mark E. Williams et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Argpyrimidine-modified Heat Shock Protein 27 in human non-small cell lung cancer: A possible mechanism for evasion of apoptosis
Jeroen W. J. van Heijst et al.
CANCER LETTERS (2006)
Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases
V. Prakash Reddy et al.
DRUG DISCOVERY TODAY (2006)
Antimelanoma activity of apoptogenic carbonyl scavengers
GT Wondrak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Carnosine as a protective factor in diabetic nephropathy -: Association with a leucine repeat of the carnosinase gene CNDP1
B Janssen et al.
DIABETES (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectives
G Aldini et al.
BIOFACTORS (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients
S Yamagishi et al.
MEDICAL HYPOTHESES (2005)
Advanced glycation end-product cross-link breakers - A novel approach to cardiovascular pathologies related to the aging process
GL Bakris et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARγ independent mechanisms
A Galli et al.
GUT (2004)
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
WK Bolton et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Glycation, inflammation, and RAGE - A scaffold for the macrovascular complications of diabetes and beyond
SF Yan et al.
CIRCULATION RESEARCH (2003)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in Northern Italy
L Bonelli et al.
PANCREAS (2003)
Novel monoclonal antibody recognition of oxidative DNA damage adduct, deoxycytidine-glyoxal
N Mistry et al.
LABORATORY INVESTIGATION (2003)
Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification
H Sakamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
分享论文
